In post-stroke brain tissue, GPR37 deficiency leads to downregulation of phosphorylated mTOR and its downstream effectors S6 kinase and 4E-BP1, particularly in regions enriched for NPCs (McCrary et al., 2019). This evidence concerns the gene GPR37 and stroke disorder.